CANDEL THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$8.33
-3.70%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-18.0%
3 months
-17.3%
6 months
+28.8%
1 year
+49.3%
Year to date
+47.4%
52-week range
$4.42 – $13.75
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$637.4M
P/E
-7.2
P/B
5.1
P/S
—
Revenue
$0
Net income
-$88.53M
Diluted EPS
-1.42
Gross margin
—
Net margin
—
Return on equity
-89.40%
Total debt
$49.52M
Cash
$201.98M
Free cash flow
-$57.29M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$38.91M | — | — | -$17.25M |
| Mar 31, 2026 | $0 | -$8.86M | — | — | -$18.71M |
| Dec 31, 2025 | $0 | -$29.5M | — | — | -$10.98M |
| Sep 30, 2025 | $0 | -$11.27M | — | — | -$10.35M |
| Jun 30, 2025 | $0 | -$4.8M | — | — | -$8.92M |
| Mar 31, 2025 | $0 | $7.38M | — | — | -$8.62M |
| Dec 31, 2024 | $0 | -$14.07M | — | — | -$5.82M |
| Sep 30, 2024 | $0 | -$10.65M | — | — | -$6.57M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CADL news
All market newsNo ticker-linked stories are in the current archive.